Yantai Dongcheng Biochemicals: Announcement of the implementation of equity distribution in 2023.
Yantai Dongcheng Biochemicals: 14 Shareholder dividend return plan for the next three years (2024-2026)
Yantai Dongcheng Biochemicals: Announcement of the 2023 Profit Distribution Plan
Yantai Dongcheng Biochemicals: Minsheng Securities Co., Ltd. sponsorship summary report on the 2021 non-public offering of shares of Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Dongcheng Pharmaceutical: An indicative announcement on the listing and circulation of restricted shares
Dongcheng Pharmaceutical: Announcement on the extension of part of the controlling shareholder\'s equity pledge
Dongcheng Pharmaceutical: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Dongcheng Pharmaceutical: Announcement on the actual controller\'s partial equity pledge
Dongcheng Pharmaceutical: Announcement on the extension of the actual controller\'s share pledge
Dongcheng Pharmaceutical: Announcement on Subsidiary Companies\' Implementation of Option Incentive Plans and Related Transactions
Dongcheng Pharmaceutical: Minsheng Securities Co., Ltd.\'s verification opinions on the implementation of option incentive plans and related transactions by companies under Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Dongcheng Pharmaceutical: Announcement on the cancellation of the pledge of some of the shares of the actual controller
Dongcheng Pharmaceutical: Announcement on the progress of a subsidiary company\'s acquisition of 100% shares in XINGIMAGING LLC
Dongcheng Pharmaceutical: Announcement on the actual controller\'s partial equity pledge
Dongcheng Pharmaceutical: Announcement on the completion of the sale of a special account to raise funds through the non-public offering of shares
Dongcheng Pharmaceutical: 2022 Equity Distribution Implementation Notice
Dongcheng Pharmaceutical: Announcement of 2022 Profit Distribution Plan
Dongcheng Pharmaceutical: Announcement on the acquisition of 100% of XING IMAGING LLC's shares by a subsidiary company
Dongcheng Pharmaceutical: Announcement on the extension of part of the controlling shareholder's equity pledge
Dongcheng Pharmaceutical: An indicative announcement on the actual controllers\' rights and interests change ratio of more than 1%
No Data